Tag: Biocon
Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
Continuing to expand its global footprint, the company has completed the integration of the acquired biosimilars business from Viatris in North America (United States and Canada) effective September 1, 2023
Biocon & Biocon Biologics release their maiden integrated annual reports for...
Reports focus on their relentless pursuit to create sustainable value for the stakeholders
Biocon Foundation & Shakti Sustainable Energy Foundation organize cities & climate...
A constructive discussion on laying the groundwork for establishing a framework for enabling philanthropies to collaborate and scale actions with stakeholders
Biocon Biologics announces positive CHMP opinion for its biosimilar to treat...
The CHMP positive opinion will be considered by the European Commission whose decision on the approval is expected by the end of September 2023
Biocon Biologics launches biosimilar ‘Hulio’ in USA
HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab) has been introduced in the United States after five years of experience in Europe and two years in Canada.
Biocon Group concludes month-long sustainability initiatives commemorating World Environment Day
Planted 1,000 saplings at Yarandahalli Lake, which is being rejuvenated by the Biocon Foundation
Biocon revenue up 59% at Rs 3,929 crore in Q4FY23
The company's revenue in biosimilars is up 114%; research services up 31% and EBITDA at Rs 1,152 crore up 75%
Biocon Academy holds graduation ceremony for 185 students
73% of graduating students are females; 100% placement achieved
Biocon awarded a Silver Medal by EcoVadis for its sustainability accomplishments
Overall Score of 66 puts Biocon in the 89th percentile in 2022 assessment
Biocon Biologics wins ‘ABEA : Bioprocessing Excellence in South Asia’ Award
The company garnered the maximum number of votes from among 70,000 biopharma professionals who participated in the survey